[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100591794":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":50,"collaborators":18,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":55,"sex":61,"minAge":62,"maxAge":18,"enrollmentInfo":63,"targetDuration":18,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":39,"whyStopped":18,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Universität Duisburg-Essen","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Exercise Intervention","EXPERIMENTAL","The supervised progressive endurance and resistance exercise program will be conducted twice per week online in small groups and will be guided by a sports scientist over a period of 12 weeks. All sessions will start with a warm-up, transitioning to endurance training, followed by strength exercises and finishing with a cool-down, and will take approximately 60 minutes. The moderate-to-high-intensity endurance training will be performed at the beginning of each training session for 15 minutes in the range of the ventilatory threshold 1 (VT1), which was obtained during the baseline cardiorespiratory exercise test. The moderate-to-high-intensity progressive resistance training and bodyweight regime will include 6 exercises that target major upper and lower body muscle groups as well as trunk exercises. Resistance exercise includes free weight, resistance bands, and bodyweight workouts.",[13],"Behavioral: Supervised 12-week Resistance and Endurance Exercise Program",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group","NO_INTERVENTION","Control group will receive usual care without an exercise program. After the final endpoint assessment, patients randomized into the control group will be offered the opportunity to participate in an exercise program conducted by the Sports and Exercise Therapy Group at WTZ Essen.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Supervised 12-week Resistance and Endurance Exercise Program","60 Minute home-based and supervised endurance, resistance and coordination training 2x\u002Fweek for 12 weeks, self-administered 20 minute home-based multimodal training 1x\u002Fweek",[9],[26],{"name":27,"affiliation":28,"role":29},"Miriam Götte, PD Dr.","University Hospital, Essen","PRINCIPAL_INVESTIGATOR",[31],{"name":32,"role":33,"phone":34,"phoneExt":18,"email":35},"Simon Basteck, M.Sc.","CONTACT","+49 201 723 3324","simon.basteck@uk-essen.de",[37],{"facility":38,"status":39,"city":40,"state":18,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":18},"University Hospital Essen","RECRUITING","Essen","45147","Germany","DE",{"type":45,"coordinates":46},"Point",[47,48],7.01228,51.45657,{"lat":48,"lon":47},{"type":29,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Miriam Götte","PD Dr.","100591794","reducing-symptom-burden-through-physical-exercise-in-melanoma-patients-100591794",false,"NCT06985056","Reducing Symptom Burden Through Physical Exercise in Melanoma Patients","Reducing Symptom Burden Through Physical Exercise in Melanoma Patients Under Immuno- or Targeted Therapy","RESPECT","Inclusion Criteria:\n\n* patients ≥ 18 years with malignant melanoma (Stage IIb - IV) receiving adjuvant or palliative immunotherapy or targeted therapy\n* patients with ECOG level 0-2\n* patients already on the same treatment protocol for at least 3 months and no more than 9 months\n* sufficient knowledge of German\n* completed and signed written consent form and completed medical history form\n* medical clearance for the exercise program and performance diagnostics\n* ability to participate in the exercise program\n* willingness to visit the study hospital for training sessions and examinations\n\nExclusion Criteria:\n\n* confirmation of contraindications for physical exercise by the attending physician (e.g. fracture risk in the case of bone metastases)\n* untreated, symptomatic, known brain metastases\n* severe neurological or cardiac impairment according to ACSM criteria\n* confirmation of respiratory insufficiency by the attending physician\n* life expectancy less than 3 months\n* physical or mental conditions that would not allow implementation of the exercise program or study protocol\n* excessive physical activity (i.e. \\>150 minutes\u002Fweek of moderate to intense physical activity and systematic intense strength\u002Fendurance training at least twice a week for one hour)","ALL","18 Years",{"count":64,"type":65},104,"ESTIMATED","INTERVENTIONAL",[68],"NA","The aim of the clinical trial is to determine whether regular exercise can reduce fatigue in adult patients with stage IIb-IV melanoma undergoing immunotherapy or targeted therapy. Additionally, we will investigate whether a supervised exercise program improves patients' quality of life, cognitive skills, and physical fitness compared to a control group without structured exercise. We will also examine other health outcomes and various blood parameters, such as interleukins and metabolites, to understand how regular activity can affect metabolism and immune function.\n\nAfter the initial assessment at the clinic, patients will be randomly assigned to two groups. Those in the intervention group will participate in a 12-week exercise program, which includes a 60-minute personalized and supervised online training session twice a week. In weeks 3, 6, and 9, one training session will be held at the clinic. Furthermore, patients in the intervention group are encouraged to complete a self-administered 20-minute exercise session once a week. The control group will not receive a supervised exercise program. Following the 12-week intervention period, another assessment will be conducted at the clinic. All patients will then enter a 6-week follow-up phase, during which neither group will receive supervised exercise training. After this follow-up phase, a final assessment of all outcomes will take place at the clinic.",[71],"Malignant Melanoma",[73,74,75,76,77,78,79],"Exercise","Fatigue","Physical Activity","Checkpoint Inhibitors","BRAF\u002FMEK Inhibitors","Melanoma","Quality of Life","2026-03-26",{"date":82,"type":83},"2026-03-27","ACTUAL",{"date":85,"type":83},"2025-08-18",{"date":87,"type":65},"2027-11",{"name":5,"class":6},1]